Imprivata OneSign Named #1 for Single Sign-on in the “2012 Best in KLAS Awards” Report
Top KLAS ranking solidifies Imprivata’s position as the premier SSO provider and healthcare IT security leader
LEXINGTON, Mass. — February 13, 2013—Imprivata, the leader in healthcare IT security, today announced that KLAS, the healthcare industry’s leading independent research firm, has named Imprivata OneSign® the Single Sign-On Category Leader in its “2012 Top 20 Best in KLAS Awards: Software & Services” report, December, 2012*. This prestigious recognition reinforces Imprivata’s position as the premier SSO provider for hospitals, and the market category leader.
“Imprivata is honored to have our customers acknowledge through KLAS our role in enabling clinicians to focus on patient care by removing hurdles to technology adoption caused by security and privacy regulations,” said Ed Gaudet, Chief Marketing Officer at Imprivata. “We remain committed to providing industry-leading healthcare IT security solutions that give clinicians back time which can be spent on quality patient care. Receiving this recognition from KLAS for the third time is a direct reflection of this focus and the world-class products and services provided by Imprivata’s engineering, support and customer success teams.”
The “2012 Top 20 Best in KLAS Awards: Software & Services” report is an overview of performance ratings for vendors offering software, professional services, and medical equipment to the healthcare industry. Individual rankings in the report are determined exclusively through active user participation and feedback from thousands of healthcare organizations. According to the KLAS report, as a Category Leader, Imprivata has excelled in its market segment and demonstrated leadership in working with customers to resolve issues and match expectations to reality.
Imprivata’s consistent leadership in the SSO category is bolstered not only by the three annual KLAS reports that have named Imprivata a Category Leader in the market segment, but Imprivata OneSign® Single Sign-On is exclusively endorsed by American Hospital Association (AHA) and received a “Strong Positive” rating by Gartner for Enterprise Single Sign-On. Currently 1,300 healthcare organizations and more than two million care providers rely on Imprivata OneSign for fast and secure access to Electronic Health Record (EHR) systems and other healthcare applications.
*©2012 KLAS Enterprises, LLC. All rights reserved.
KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and to be counted. Working with thousands of healthcare executives and clinicians, KLAS gathers data on software, services, medical equipment, and infrastructure systems to deliver timely reports, trends, and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving vendor performance. KLAS was founded in 1996, and their staff and advisory board average 25 years of healthcare information technology experience. Follow KLAS on Twitter at www.twitter.com/KLASresearch.
Imprivata, the leader in healthcare IT security, enables secure access and collaboration for two million healthcare users worldwide. As the #1 independent provider of single sign-on and access management solutions for healthcare and other regulated industries, Imprivata OneSign® Single Sign-On is exclusively endorsed by American Hospital Association (AHA) and recognized by Gartner and KLAS. The company hospitals trust with securing their patient information now offers Imprivata Cortext®, the healthcare industry’s first free, HIPAA compliant text messaging solution designed for physicians and nurses. Headquartered in Lexington, Massachusetts, Imprivata serves 1,300 hospitals in partnership with over 200 EMR and technology infrastructure vendors around the world. For more information, please visit www.imprivata.com.
All Imprivata products are trademarks of Imprivata, Inc. in the USA and other countries. All other product or company names mentioned are the property of their respective owners.